These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
11. Dopaminergic drugs in development for Parkinson's disease. Korczyn AD Adv Neurol; 2003; 91():267-71. PubMed ID: 12442685 [No Abstract] [Full Text] [Related]
12. What has been learnt from study of dopamine receptors in Parkinson's disease? Hurley MJ; Jenner P Pharmacol Ther; 2006 Sep; 111(3):715-28. PubMed ID: 16458973 [TBL] [Abstract][Full Text] [Related]
13. Three types of akinesia in the progressive course of Parkinson's disease. Narabayashi H Adv Neurol; 1993; 60():18-24. PubMed ID: 8093577 [No Abstract] [Full Text] [Related]
18. Recognition and treatment of response fluctuations in Parkinson's disease: review article. Verhagen Metman L Amino Acids; 2002; 23(1-3):141-5. PubMed ID: 12373528 [TBL] [Abstract][Full Text] [Related]
19. New perspectives in the treatment of Parkinson's disease. LeWitt PA Clin Neuropharmacol; 1986; 9 Suppl 1():S37-54. PubMed ID: 3085929 [No Abstract] [Full Text] [Related]